Pyc Therapeutics (PYC.AX) traded down -1.66 % during a 24 hours period ending at 06:59 PM Central Europe on Monday 26th. One Pyc Therapeutics stock can currently be bought for about AUD 1.76 on popular exchanges. Current supply of Pyc Therapeutics stocks is 984.2 mn. Pyc Therapeutics has a current market capitalization of AUD 1.8 bn and approximately AUD 5.1 mn worth of Pyc Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Pyc Therapeutics has traded -38.83 % down. Simple moving average of last 200 days is at AUD 1.68. The highest price of past 52 weeks was recorded at AUD 2.93 on 09/21/2026. 52 weeks low was at AUD 1.04 on 04/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Perpetual (PPT.AX) traded up 2.95 % and now trades at AUD 17.3. Perpetual has a market capitalisation of AUD 2 bn. Current price/earnings ratio for Perpetual is 33.7.

  • Domino’s Pizza L (DMP.AX) traded down -1.6 % and now trades at AUD 21.52. Domino’s Pizza L has a market capitalisation of AUD 2 bn.

  • Alkane (ALK.AX) traded down -10.88 % and now trades at AUD 1.44. Current market capitalisation for Alkane is AUD 2 bn. Current price/earnings ratio for Alkane is 8.49.

  • Bellevue Gold (BGL.AX) traded down -5.78 % and now trades at AUD 1.34. Bellevue Gold has a market capitalisation of AUD 1.9 bn. Current price/earnings ratio for Bellevue Gold is 279.79.

  • Deterra Royalties (DRR.AX) traded down -1.03 % and now trades at AUD 3.85. Deterra Royalties has a market capitalisation of AUD 2 bn. Current price/earnings ratio for Deterra Royalties is 13.72. On 26 October 2026, Deterrra Royalties Ltd announced that a substantial holder had ceased to hold a significant voting interest in the company. The notice, filed under the Corporations Act, confirms that the holder’s substantial holdings ended on 22 October. The announcement follows a series of adjustments to the holder’s voting interests, including transfers and collateral arrangements involving several State Street subsidiaries and other financial entities. While the disclosure details the nature and timing of these changes, it does not disclose specific monetary values or impact on the company’s share price. The filing indicates that the holder has fulfilled its reporting obligations, and no further regulatory action has been reported at this time.

About Pyc Therapeutics

Pyc Therapeutics Ltd is a pharmaceutical company operating in Australia that specializes in developing drugs and medicines for various types of diseases. The company serves its customers within the country.